Navigation Links
Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
Date:5/6/2009

failure of pixantrone to prove safe and effective for treatment of relapsed aggressive NHL as determined by the FDA, the possibility that the NDA submission will not be completed in the second quarter of 2009, that priority review will not be granted by the FDA and that a decision by the FDA is not rendered in late 2009, the possibility that we may not receive all of the additional amount owed to us by Spectrum, our ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in our filings with the Securities and Exchange Commission including, without limitation, our most recent filings on Forms 10-K, 8-K, and 10-Q. Except as may be required by law, we do not intend to update or alter our forward-looking statements whether as a result of new information, future events, or otherwise.

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: media@ctiseattle.com
    www.celltherapeutics.com/media.htm

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors.htm

                                              Three Months Ended
                                                   March 31,
                                                   ---------
                                                2009        2008
                                                ----        ----
    Revenues:
      Product sales                               $-      $3,374
      License and contract revenue                20          20
                                           
'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
2. Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
3. Cornerstone Therapeutics to Host First Quarter 2009 Conference Call
4. Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
5. InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
6. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
7. TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
8. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
9. Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
10. Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone
11. Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2015)... With the implementation of the Affordable Care ... difficult to provide their employees with a viable healthcare ... for employees stand to face strict penalties. Never before ... of a business’s success or failure. In an effort ... Doctors has created a varying level of less expensive ...
(Date:5/23/2015)... May 23, 2015 Javon Bea ... the Sports Medicine and Rehabilitation Center, 557 N. Washington ... Mondays, June 1-July 20, 5:30-6:30 pm. , The 8-week ... and Laurie Finke, RN, BSN, who will offer training ... on nutrition, running mechanics and show selection and weekly ...
(Date:5/22/2015)... May 22, 2015 The American College ... events in June. They will hold a webinar on ... a two-day class on Classical Chinese Medicine. , Webinar ... Dr. Steve Given, the Dean of Clinical Education, will ... new First Professional Doctorate program. ACTCM is currently developing ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Omar Ahmad ... selected to participate in the 2015 Congress of Future ... described as a gathering of “America’s highest achieving high ... areas of healthcare, set new goals and learn better ... a live surgery, during which we can ask the ...
(Date:5/22/2015)... Pa (PRWEB) May 22, 2015 ... (AHN) today announced a new partnership to develop ... for the region. The initiative includes a new exhibit ... live demonstration theater, and a new traveling science ... the fall of 2015. , Designed to explore ...
Breaking Medicine News(10 mins):Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4
... , Jan. 13 WellPoint, Inc. (NYSE: ... a "2010 Diversity Leader Award®" in the January/February issue of ... communication practices during the past year. , WellPoint continues ... inclusion practices and has received multiple honors in recent years ...
... ... products direct to patients which will reduce operating costs for providers and improve patient ... Plainview, ... announced today a strategic alliance designed to automate the shipping of CPAP products ...
... ... your health , ... the gym and cheaper than cosmetic surgery or even your nighttime moisturizer, turning up the heat ... and your health., , , , ,“An active sex life will make you healthier, buffer, younger ...
... ... advertising executive launches RedSquare360 to accommodate manufacturers, and web retailers, growing demands for 3D ... to help ecommerce clients increase conversion rates. , ... (PRWEB) January 13, 2010 -- Online retailers know the ...
... ... Microbix will maintain sales and marketing functions while Therapure will manage manufacturing, distribution ... ... Biosystems Inc. (MBX:TSX) a biotechnology company focused on virology and biological technologies, and ...
... ... firm striving to help families with wide range of legal needs. , ... New Brunswick, N.J. (Lexis Nexis) January 13, 2010 ... resources and skilled legal professionals that will help them navigate the state,s court system, ...
Cached Medicine News:Health News:WellPoint, Inc. Receives 2010 Diversity Leader Award(R) 2Health News:WellPoint, Inc. Receives 2010 Diversity Leader Award(R) 3Health News:Fastrack & cpapdropship.com Form Alliance to Reduce Provider Costs 2Health News:Fastrack & cpapdropship.com Form Alliance to Reduce Provider Costs 3Health News:Frequent and Fabulous Sex -- A Menopausal Woman's Surprising Fountain of Youth 2Health News:Frequent and Fabulous Sex -- A Menopausal Woman's Surprising Fountain of Youth 3Health News:360 Images Give Online Consumers A Product 'Demo' Before Purchasing. 2Health News:360 Images Give Online Consumers A Product 'Demo' Before Purchasing. 3Health News:Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry 2Health News:Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry 3Health News:Shamy & Shamy Launches New Web Site Providing Simple Access to Free Online Resources for New Jersey Court System 2
(Date:5/22/2015)... May 22, 2015  In a sweeping analysis assessing ... T1D Exchange researchers conclude that there remains ... diabetes across all age groups, but especially for adolescents ... picture of diabetes treatment, underscoring the need to address ... that can help type 1 patients achieve optimal metabolic ...
(Date:5/22/2015)... , May 22, 2015 AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... that interim chief executive officer Howie Rosen ... chief financial officer Tim Morris will be ... the two presentations are as follows: Jefferies ...
(Date:5/21/2015)... , May 21, 2015 ... ) has announced the addition of the ... Type (Ankle Replacement, Digit Replacement, Elbow Replacement, ... Forecast to 2019" report to their ... for knee replacement was valued at $4,470.9 ...
Breaking Medicine Technology:Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2
... , ROCKVILLE, Md., Dec. 9 Novavax, ... 25, 2009, it closed its previously announced public offering of ... Novavax received net proceeds from the sale of the ... approximately $21 million, which will be used for preclinical studies ...
... , GAITHERSBURG, Md, Dec. 9 Lentigen Corporation, ... of lentiviral gene delivery technologies, announced today that it ... business innovation research (SBIR) grant for a program on ... using Lentivirus". In this program, Lentigen will collaborate ...
Cached Medicine Technology:NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2
Serology provides a minimally-invasive, sensitive and easy-to-perform method for the determination of H. pylori infection. The Bio-Rad H. pylori qualitative test kits use EIA technology for the deter...
... effective and relatively bloodless procedure for immediate ... to learn and can be performed in ... setting with few if any patient complications. ... OR time and use a familiar technology ...
... IFA Test kit is a user-friendly ... in dropper bottles. A single monoclonal ... identify all serogroups of L. pneumophilia ... culture isolates, confirming a diagnosis of ...
... of the most innovative and elegantly simple ... provides an ideal solution for physicians seeking ... other option provides a better combination of ... System heats, circulates, and maintains precise control ...
Medicine Products: